US 11001603
Modulators of 5′-nucleotidase, ecto and the use thereof
granted A61KA61K31/70A61K31/7052
Quick answer
US patent 11001603 (Modulators of 5′-nucleotidase, ecto and the use thereof) held by Arcus Biosciences, Inc. expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arcus Biosciences, Inc.
- Grant date
- Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K31/70, A61K31/7052, A61K31/706, A61K31/7064